Gary Charles Robb, Chief Financial Officer at CORCEPT THERAPEUTICS INC (CORT), bought 5,600 shares at $9.75 ($55K) on 2017-05-04, disclosed to the SEC on 2017-05-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| CORT | SELL | 2025-06-18 | $451K | — | Filing → |
| CORT | SELL | 2025-05-22 | $346K | — | Filing → |
| CORT | SELL | 2025-01-06 | $556K | — | Filing → |